IL-1RAP: novel target for chemotherapy-induced neuropathy (2024–2025)

Grant type:
Cantargia AB
Researchers:
  • NHMRC Leadership Fellow - Group Lea
    School of Pharmacy
    Faculty of Health and Behavioural Sciences
    NHMRC Leadership Fellow - Group Lea
    Institute for Molecular Bioscience
  • Research Fellow
    Institute for Molecular Bioscience
Funded by:
Cantargia AB